NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.

Yu-Qiong YangTian TianHua-Yuan ZhuJin-Hua LiangWei WuJia-Zhu WuYi XiaLi WangLei FanJian-Yong LiWei Xu

Published in: BMC cancer (2018)

NDRG2 mRNA levels might be a useful prognostic variable for patients of CLL and up-regulating NDRG2 transcription may be a therapy approach in CLL without p53 aberrations.

Keyphrases

chronic lymphocytic leukemia
end stage renal disease
ejection fraction
newly diagnosed
cell proliferation
long non coding rna
prognostic factors
peritoneal dialysis
binding protein
gene expression
long noncoding rna
patient reported outcomes
bone marrow
cell therapy
genome wide